Hanover, NH · Founded 2000 · Privately Held (backing)
Developer of a gene therapy platform designed for a rare genetic eye disorder that typically presents with severe progressive visual impairment. Hubble Therapeutics is based in Hanover, NH and was founded in 2000. It has raised $20.3 million across 1 recorded round; the latest was a $9.8 million early-stage round in Oct 2024.
Last price · $/share
—
Implied valuation
—
Total raised
$20.3M
Last round
Early Stage VC
Oct 2024
Cap table — not yet on record
Hubble Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Private Market View
More of Hubble Therapeutics with a free Private Market View account
·Watch Hubble Therapeutics: the Monday email on marks, rounds and moves
Where does Hubble Therapeutics's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Hubble Therapeutics's 1 recorded funding rounds.
